Venrock Healthcare Capital Partners III, L.P. and Affiliates File Schedule 13G for Vor Biopharma Inc.

Venrock Healthcare Capital Partners III, L.P. (VHCP III), along with its affiliates VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P. (VHCP EG), VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah, and Bong Koh, have filed a Schedule 13G with the SEC regarding their beneficial ownership of Vor Biopharma Inc. common stock. The filing indicates that the Reporting Persons collectively own 9.99% of the outstanding shares of Vor Biopharma Inc. as of September 18, 2025. The ownership includes shares of common stock and pre-funded warrants, which are subject to a Beneficial Ownership Blocker that limits the exercise of the warrants to prevent ownership from exceeding 9.99% of the outstanding shares. The filing also includes a Joint Filing Agreement and Powers of Attorney for Bong Koh and Nimish Shah.